BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA). Ergänzende Stellungnahme der DOG, der RG und des BVA zur Therapie der proliferativen diabetischen Retinopathie: Stand November 2019. Ophthalmologe 2020;117:755-9. [DOI: 10.1007/s00347-020-01116-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lang GE, Stahl A, Voegeler J, Quiering C, Zaremba L, Lorenz K, Spital G, Liakopoulos S. Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study. Acta Ophthalmol 2022;100:e578-87. [PMID: 34121335 DOI: 10.1111/aos.14907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hagenau F, Herold T. Diabetische Retinopathie – Handlungspfad. Augenheilkunde up2date 2021;11:297-301. [DOI: 10.1055/a-1553-9202] [Reference Citation Analysis]
3 Hagenau F, Herold T. Diabetische Retinopathie – Handlungspfad. Klin Monbl Augenheilkd. [DOI: 10.1055/a-1667-6207] [Reference Citation Analysis]
4 Barth T, Helbig H. [Diabetic retinopathy]. Klin Monbl Augenheilkd 2021. [PMID: 34380155 DOI: 10.1055/a-1545-9927] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Barth T, Helbig H. Diabetische Retinopathie. Augenheilkunde up2date 2021;11:231-47. [DOI: 10.1055/a-1262-3160] [Reference Citation Analysis]
6 Ulbig M. [The Eye in Internal Medicine: Diabetic retinopathy]. Dtsch Med Wochenschr 2021;146:874-81. [PMID: 34256400 DOI: 10.1055/a-1271-2043] [Reference Citation Analysis]